Research graph
References from Increased HIF-2α and CD105 (endoglin) expression is associated with poor differentiation in pheochromocytomas and paragangliomas. Local targets link to admitted publications; unresolved targets remain external evidence.
Japan Endocrine Society Clinical Practice Guideline for the diagnosis and management of pheochromocytoma and paraganglioma 2025
10.1507/endocrj.ej25-0165 · 2026 · External reference
Personalized management of pheochromocytoma and paraganglioma
10.1210/endrev/bnab019 · 2022 · External reference
Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas
10.1007/s12022-022-09704-6 · 2022 · External reference
Pheochromocytoma of the adrenal gland scaled score (PASS) to separate benign from Malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases
10.1097/00000478-200205000-00002 · 2002 · External reference
Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma
10.1530/erc-13-0494 · 2014 · External reference
The value of histological algorithms to predict the Malignancy potential of pheochromocytomas and abdominal paragangliomas—a meta-analysis and systematic review of the literature
10.3390/cancers11020225 · 2019 · External reference
Predicting metastatic potential in pheochromocytoma and paraganglioma: a comparison of PASS and GAPP scoring systems
10.1210/clinem/dgaa608 · 2020 · External reference
Comprehensive molecular characterization of pheochromocytoma and paraganglioma
10.1016/j.ccell.2017.01.001 · 2017 · External reference
Tumour microenvironment in pheochromocytoma and paraganglioma
10.3389/fendo.2023.1137456 · 2023 · External reference
Current views on the role of HIF-2α in the pathogenesis and syndromic presentation of pheochromocytoma and paraganglioma
10.1016/j.beem.2024.101955 · 2024 · External reference
Endoglin in head and neck neoplasms
10.3389/fmed.2023.1115212 · 2023 · External reference
Validation of pathological grading systems for predicting metastatic potential in pheochromocytoma and paraganglioma
10.1371/journal.pone.0187398 · 2017 · External reference
Study of microvessel density and the expression of vascular endothelial growth factors in adrenal gland pheochromocytomas
10.1155/2014/104129 · 2014 · External reference
10.1016/j.jcm.2016.02.012 · 2016 · Admitted local publication
Pathophysiology and acute management of tachyarrhythmias in pheochromocytoma: JACC review topic of the week
10.1016/j.jacc.2020.04.080 · 2020 · External reference
Genetic and molecular biomarkers in aggressive pheochromocytomas and paragangliomas
10.3390/ijms25137142 · 2024 · External reference
Endoglin (CD105): a review of its role in angiogenesis and tumor diagnosis, progression and therapy
2011 · External reference
Tumor microenvironment heterogeneity: an important mediator of prostate cancer progression and therapeutic resistance
10.1038/s41698-022-00272-w · 2022 · External reference
The prognostic significance of BMI1 expression in invasive breast cancer is dependent on its molecular subtypes
10.1007/s10549-020-05719-x · 2020 · External reference
Endoglin (CD105) as a putative prognostic biomarker for colorectal cancer: a systematic review
10.15386/mpr-2120 · 2022 · External reference
Endoglin/CD105-based imaging of cancer and cardiovascular diseases: a systematic review
10.3390/ijms22094804 · 2021 · External reference
CD105 (Endoglin) expression as a prognostic marker in aggressive papillary thyroid carcinoma
10.1111/cen.15290 · 2025 · External reference
Comprehensive investigation of angiogenesis, PASS score and immunohistochemical factors in risk assessment of Malignancy for paraganglioma and pheochromocytoma
10.3390/diagnostics14080849 · 2024 · External reference
Targeting VEGF signaling for tumor microenvironment remodeling and metastasis inhibition: therapeutic strategies and insights
10.1016/j.biopha.2025.118023 · 2025 · External reference
Role of VEGF-A and its receptors in sporadic and MEN2-associated pheochromocytoma
10.3390/ijms15045323 · 2014 · External reference
Von Hippel-Lindau disease: insights into oxygen sensing, protein degradation, and cancer
10.1172/jci162480 · 2022 · External reference
Expression of HIF-1alpha, HIF-2alpha (EPAS1), and their target genes in paraganglioma and pheochromocytoma with VHL and SDH mutations
10.1210/jc.2006-0920 · 2006 · External reference
Local-regional recurrence of pheochromocytoma/paraganglioma: characteristics, risk factors and outcomes
10.3389/fendo.2021.762548 · 2021 · External reference
Prognostic significance of Ki-67 in assessing the risk of progression, relapse or metastasis in pheochromocytomas and paragangliomas
10.1080/07853890.2025.2478312 · 2025 · External reference
Paraganglioma and phaeochromocytoma: from genetics to personalized medicine
10.1038/nrendo.2014.188 · 2015 · External reference
Succinate dehydrogenase (SDH)-deficient neoplasia
10.1111/his.13277 · 2018 · External reference
Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction
10.1093/jnci/djt201 · 2013 · External reference
Prognostic value of [18F]FDG-PET prior to [131I]MIBG treatment for pheochromocytoma and paraganglioma (PPGL)
10.1007/s12149-022-01798-6 · 2023 · External reference
